See more : BOE Technology Group Company Limited (200725.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Mirion Technologies, Inc. (MIR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mirion Technologies, Inc., a leading company in the Industrial – Machinery industry within the Industrials sector.
- Charbone Hydrogen Corporation (CHHYF) Income Statement Analysis – Financial Results
- Hangzhou First Applied Material Co., Ltd. (603806.SS) Income Statement Analysis – Financial Results
- Mastek Limited (MASTEK.BO) Income Statement Analysis – Financial Results
- FTAC Zeus Acquisition Corp. (ZINGW) Income Statement Analysis – Financial Results
- Paltac Corporation (8283.T) Income Statement Analysis – Financial Results
Mirion Technologies, Inc. (MIR)
About Mirion Technologies, Inc.
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 800.90M | 717.80M | 322.10M | 478.20M | 440.10M | 444.10M |
Cost of Revenue | 444.50M | 400.60M | 241.00M | 281.20M | 251.80M | 275.70M |
Gross Profit | 356.40M | 317.20M | 81.10M | 197.00M | 188.30M | 168.40M |
Gross Profit Ratio | 44.50% | 44.19% | 25.18% | 41.20% | 42.79% | 37.92% |
Research & Development | 31.70M | 30.30M | 17.00M | 15.90M | 14.00M | 19.30M |
General & Administrative | 337.30M | 355.40M | 124.90M | 1.37M | 341.00 | -599.71K |
Selling & Marketing | 1.30M | 1.70M | 800.00K | 900.00K | 800.00K | 600.00K |
SG&A | 340.10M | 357.10M | 125.70M | 1.37M | 341.00 | 295.00 |
Other Expenses | 6.50M | 5.20M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 378.30M | 392.60M | 142.70M | 1.37M | 341.00 | 295.00 |
Cost & Expenses | 822.80M | -181.30M | 383.70M | 1.37M | 341.00 | 295.00 |
Interest Income | 4.80M | 41.90M | 145.80M | 149.20M | 143.50M | 128.90M |
Interest Expense | 61.90M | 42.50M | 59.00M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 162.80M | 173.90M | 62.90M | 68.40M | 69.50M | 77.00M |
EBITDA | 114.30M | -90.80M | -19.20M | 22.88M | 98.40M | 72.30M |
EBITDA Ratio | 14.27% | 14.53% | 0.40% | -0.30% | 0.00% | 0.00% |
Operating Income | -21.90M | 266.90M | -61.60M | -1.37M | -341.00 | -300.00 |
Operating Income Ratio | -2.73% | 37.18% | -19.12% | -0.29% | 0.00% | 0.00% |
Total Other Income/Expenses | -83.40M | -8.80M | -72.40M | -24.31M | -28.80M | 4.70M |
Income Before Tax | -105.30M | -306.60M | -141.10M | -1.31M | -341.00 | -295.00 |
Income Before Tax Ratio | -13.15% | -42.71% | -43.81% | -0.27% | 0.00% | 0.00% |
Income Tax Expense | -6.60M | 18.20M | -12.40M | -265.90K | 4.20M | 36.80M |
Net Income | -96.90M | -324.80M | -127.90M | -1.04M | -341.00 | -295.00 |
Net Income Ratio | -12.10% | -45.25% | -39.71% | -0.22% | 0.00% | 0.00% |
EPS | -0.49 | -1.79 | -0.61 | -0.02 | 0.00 | 0.00 |
EPS Diluted | -0.49 | -1.79 | -0.61 | -0.02 | 0.00 | 0.00 |
Weighted Avg Shares Out | 196.37M | 181.15M | 208.08M | 56.99M | 20.13M | 95.13M |
Weighted Avg Shares Out (Dil) | 196.37M | 181.15M | 208.08M | 56.99M | 20.13M | 95.13M |
The9 Obtained Exclusive Publishing License of "MIR M" IP, A New Chinese Edition of Mobile and PC Game from Wemade
Mirion Announces Completion of Redemption of its Outstanding Public Warrants
Mirion to Present at Jefferies' 2024 Global Healthcare Conference
Mirion Reminds Investors of Redemption of Public Warrants
Mirion Technologies, Inc. (MIR) Q1 2024 Earnings Call Transcript
Mirion Announces First Quarter 2024 Financial Results and Reaffirms Full Year Guidance
Mirion Announces Redemption of Public Warrants
Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024
Mirion to Present at B. Riley Securities' Radiopharma Day
Mirion to Participate in SHARE Series Fireside Chat on Monday, February 26, 2024
Source: https://incomestatements.info
Category: Stock Reports